Designed to reduce environmental impacts, the project will support the DePuy Synthes and Janssen Biologics manufacturing operations while boosting competitiveness and lowering energy costs by as much as 30% at both sites.
Recently, Johnson & Johnson had announced its investment of €80m as well as the creation of 270 jobs at its new Ethicon Biosurgery manufacturing facility in Limerick.
Sherlock said that the investment represents the Cork plants’ efforts for reducing costs while maintaining competitiveness.
"Wind energy will safeguard jobs, provide security of energy supply, help Ireland meet its EU carbon reduction targets and reduce our dependence on expensive fossil fuels," Sherlock added.
On behalf of Johnson & Johnson, Global Orthopaedics Group Supply Chain vice president Willem Appelo said, "We are committed to minimising environmental impacts across our operations."
The wind turbine project has been developed jointly by Johnson & Johnson, GSK and Novartis – the Cork Lower Harbour Energy Group.
